|
|
|
Volumn 49, Issue 1, 2002, Pages 220-223
|
|
In vitro activity of faropenem and 20 other compounds against β-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs [5]
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
ANTIBIOTIC AGENT;
BETA LACTAMASE;
CEFACLOR;
CEFEPIME;
CEFIXIME;
CEFOTAXIME;
CEFPODOXIME;
CEFPROZIL;
CEFTIBUTEN;
CEFUROXIME;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
CLINAFLOXACIN;
FROPENEM;
GATIFLOXACIN;
GEMIFLOXACIN;
LEVOFLOXACIN;
LOCARBEF;
MACROLIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TETRACYCLINE;
UNCLASSIFIED DRUG;
ANTIMICROBIAL ACTIVITY;
BACTERIUM ISOLATE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
HAEMOPHILUS INFLUENZAE;
HUMAN;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
MORAXELLA CATARRHALIS;
NONHUMAN;
PHENOTYPE;
POLYMERASE CHAIN REACTION;
SERUM;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMASES;
BETA-LACTAMS;
HAEMOPHILUS INFLUENZAE;
HUMANS;
LACTAMS;
MICROBIAL SENSITIVITY TESTS;
MORAXELLA (BRANHAMELLA) CATARRHALIS;
|
|
EID: 0036156610
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (11)
|
|
References (6)
|
